clofibrate has been researched along with pentoxifylline in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (10.00) | 29.6817 |
| 2010's | 4 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bellows, DS; Clarke, ID; Diamandis, P; Dirks, PB; Graham, J; Jamieson, LG; Ling, EK; Sacher, AG; Tyers, M; Ward, RJ; Wildenhain, J | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Bokarev, IN; Komarov, FI; Liusov, VA | 1 |
| Zicot, M | 1 |
| le Petit, G | 1 |
| Bertha, G; Lechner, H; Ott, E | 1 |
| Granzer, E; Weithmann, KU | 1 |
3 review(s) available for clofibrate and pentoxifylline
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[is there a treatment for peripheral arterial insufficiency?].
Topics: Arterial Occlusive Diseases; Arteriosclerosis; Aspirin; Clofibrate; Dipyridamole; Fibrinolytic Agents; Humans; Pentoxifylline; Snake Venoms; Xanthinol Niacinate | 1979 |
Therapeutical aspects of cerebrovascular disease.
Topics: Aspirin; Blood Coagulation; Cerebrovascular Disorders; Clofibrate; Dipyridamole; Erythrocyte Aggregation; Erythrocytes; Humans; Ischemic Attack, Transient; Pentoxifylline; Plasma; Platelet Aggregation; Sulfinpyrazone | 1983 |
1 trial(s) available for clofibrate and pentoxifylline
| Article | Year |
|---|---|
[Pharmacological action on the thrombocyte link in hemostasis in the treatment of ischemic heart disease].
Topics: Aspirin; Blood Platelet Disorders; Blood Platelets; Clinical Trials as Topic; Clofibrate; Coronary Disease; Dipyridamole; Drug Evaluation; Hemostasis; Humans; Pentoxifylline; Phenothiazines; Piperazines; Pyridinolcarbamate | 1978 |
6 other study(ies) available for clofibrate and pentoxifylline
| Article | Year |
|---|---|
Chemical genetics reveals a complex functional ground state of neural stem cells.
Topics: Animals; Cell Survival; Cells, Cultured; Mice; Molecular Structure; Neoplasms; Neurons; Pharmaceutical Preparations; Sensitivity and Specificity; Stem Cells | 2007 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
[The pH-dependent lipid solubility of drug groups].
Topics: Adrenergic beta-Antagonists; Anesthetics, Local; Caffeine; Clofibrate; Hydrogen-Ion Concentration; Lipids; Pentoxifylline; Pharmaceutical Preparations; Solubility | 1985 |
Stimulation of anti-aggregatory activity from rat aorta by hypolipidemic drugs.
Topics: Animals; Aorta; Cattle; Clofibrate; Clofibric Acid; Epoprostenol; Humans; Hydrogen-Ion Concentration; Lipids; Male; Nicotinic Acids; Pentoxifylline; Platelet Aggregation; Rats | 1980 |